GBCS SELECTIS HEALTH, INC. revenue, earnings and financials

For the quarter ended June 30, 2026, SELECTIS HEALTH, INC. reported revenue of $4.73M (down 54.7% from a year earlier), net income of $8.12M and diluted EPS of $2.35; over the last four quarters revenue was $32.5M and net income $14.6M; for the fiscal year ended December 2025 revenue was $41.4M, up 4.9% on the year before.

GBCS annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $41.4M, gross profit n/a, operating income −$1.56M, net income −$1.02M (margin -2.5%), EPS −$0.34
• Fiscal year ended Dec 2024: revenue $39.5M, gross profit n/a, operating income −$2.73M, net income −$2.42M (margin -6.1%), EPS −$0.80
• Fiscal year ended Dec 2023: revenue $36.8M, gross profit n/a, operating income −$8.96M, net income −$3.97M (margin -10.8%), EPS −$1.31
• Fiscal year ended Dec 2022: revenue $40.6M, gross profit n/a, operating income −$287K, net income −$2.40M (margin -5.9%), EPS −$0.79
• Fiscal year ended Dec 2021: revenue $29.3M, gross profit n/a, operating income −$729K, net income −$2.25M (margin -7.7%), EPS −$0.82

GBCS quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $4.73M (down 54.7% year over year), net income $8.12M, EPS $2.35
• Quarter ended Mar 31, 2026: revenue $7.29M (down 30.5% year over year), net income $6.53M, EPS $1.90
• Quarter ended Dec 31, 2025 (from the annual report): revenue $9.67M (down 7.0% year over year), net income −$804K, EPS −$0.26
• Quarter ended Sep 30, 2025: revenue $10.8M (up 8.2% year over year), net income $752K, EPS $0.24
• Quarter ended Jun 30, 2025: revenue $10.4M (up 8.9% year over year), net income −$308K, EPS −$0.10
• Quarter ended Mar 31, 2025: revenue $10.5M (up 10.5% year over year), net income −$656K, EPS −$0.22
• Quarter ended Dec 31, 2024 (from the annual report): revenue $10.4M (up 13.0% year over year), net income −$576K, EPS −$0.20
• Quarter ended Sep 30, 2024: revenue $10.0M (up 10.7% year over year), net income −$1.61M, EPS −$0.52
• Quarter ended Jun 30, 2024: revenue $9.58M (up 7.3% year over year), net income $794K, EPS $0.26
• Quarter ended Mar 31, 2024: revenue $9.49M (down 1.2% year over year), net income −$1.03M, EPS −$0.34
• Quarter ended Dec 31, 2023 (from the annual report): revenue $9.20M (down 2.7% year over year), net income −$3.63M, EPS −$1.20
• Quarter ended Sep 30, 2023: revenue $9.05M (down 5.6% year over year), net income −$2.26M, EPS −$0.74
• Quarter ended Jun 30, 2023: revenue $8.93M (down 22.1% year over year), net income −$2.10M, EPS −$0.69
• Quarter ended Mar 31, 2023: revenue $9.61M (down 4.8% year over year), net income $4.03M, EPS $1.32
• Quarter ended Dec 31, 2022 (from the annual report): revenue $9.46M (down 7.2% year over year), net income −$2.19M, EPS −$0.87
• Quarter ended Sep 30, 2022: revenue $9.58M (up 30.9% year over year), net income −$991K, EPS −$0.33
• Quarter ended Jun 30, 2022: revenue $11.5M (up 90.7% year over year), net income $750K, EPS $0.34
• Quarter ended Mar 31, 2022: revenue $10.1M (up 75.1% year over year), net income $37.1K, EPS $0.07
• Quarter ended Dec 31, 2021 (from the annual report): revenue $10.2M, net income −$1.77M, EPS −$0.63
• Quarter ended Sep 30, 2021: revenue $7.32M, net income −$53.0K, EPS −$0.02

GBCS cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $1.88M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$1.82M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $537K, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$305K, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$271K, share buybacks n/a

GBCS balance sheet

• Jun 30, 2026: cash $7.73M, total assets $31.5M, total liabilities $23.5M, shareholders' equity $7.97M, long-term debt $11.6M
• Mar 31, 2026: cash $1.29M, total assets $30.0M, total liabilities $30.2M, shareholders' equity −$143K, long-term debt $13.3M
• Dec 31, 2025: cash $1.01M, total assets $32.6M, total liabilities $39.2M, shareholders' equity −$6.61M, long-term debt $13.4M
• Sep 30, 2025: cash $417K, total assets $33.3M, total liabilities $38.9M, shareholders' equity −$5.65M, long-term debt $18.5M
• Jun 30, 2025: cash $560K, total assets $33.6M, total liabilities $40.0M, shareholders' equity −$6.80M, long-term debt $18.7M
• Mar 31, 2025: cash $1.29M, total assets $34.5M, total liabilities $40.6M, shareholders' equity −$6.48M, long-term debt $19.0M
• Dec 31, 2024: cash $680K, total assets $33.4M, total liabilities $38.9M, shareholders' equity −$5.81M, long-term debt $19.1M
• Sep 30, 2024: cash n/a, total assets $33.9M, total liabilities $38.8M, shareholders' equity −$4.83M, long-term debt $18.5M

What is GBCS's revenue?

SELECTIS HEALTH, INC. reported $32.5M of revenue over its last four quarters, through June 30, 2026.

Is GBCS profitable?

Yes. SELECTIS HEALTH, INC. earned $14.6M over the last four quarters.

What is GBCS's EPS?

Diluted earnings per share over the last four quarters were $4.23; $2.35 in the latest quarter.

GBCS ownership and insider trades · All stocks